Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr Intensive Care ; 7(2): 86-89, 2018 Jun.
Article in English | MEDLINE | ID: mdl-31073476

ABSTRACT

In this article, we present the case of a 6-year-old female presented to the emergency department with progressive ascending motor weakness leading to cardiac arrest. The recent medical history included neck trauma 1 month prior to admission, 2 weeks of subjective fevers, and 1 day of urinary incontinence. After stabilization, and a review of the recent signs and symptoms, a magnetic resonance imaging of the neck revealed a posterior neck mass from C2 to T2. Neurosurgical removal of the mass was consistent with Ewing's sarcoma. Neck pain is a common presentation in the pediatric population, with the most common cause being traumatic. When coupled with neurological deficits, further studies are warranted to evaluate for organic causes.

2.
Tex Heart Inst J ; 39(5): 724-6, 2012.
Article in English | MEDLINE | ID: mdl-23109779

ABSTRACT

Conivaptan is a nonspecific arginine vasopressin receptor antagonist that has been used as therapy in adults who have hypervolemic hyponatremia due to congestive heart failure. Its use in children with congestive heart failure has not been reported. We describe the use of conivaptan in a 4-month-old infant girl with severe hypervolemic hyponatremia and heart failure. A therapeutic weight-based dose was extrapolated from the adult dose. Conivaptan therapy was administered for 48 hours, after which the patient recovered from her hyponatremia without untoward effects. Arginine vasopressin receptor antagonists such as conivaptan may be useful as therapy for hyponatremia associated with heart failure. Further studies are required before conivaptan can be recommended for routine use in children.


Subject(s)
Benzazepines/therapeutic use , Heart Failure/complications , Hormone Antagonists/therapeutic use , Hyponatremia/drug therapy , Neurophysins/antagonists & inhibitors , Protein Precursors/antagonists & inhibitors , Vasopressins/antagonists & inhibitors , Female , Heart Failure/diagnosis , Heart Failure/metabolism , Humans , Hyponatremia/diagnosis , Hyponatremia/etiology , Hyponatremia/metabolism , Infant , Neurophysins/metabolism , Protein Precursors/metabolism , Severity of Illness Index , Treatment Outcome , Vasopressins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL